26.70
price down icon1.29%   -0.35
after-market  Dopo l'orario di chiusura:  26.70 
loading

DENTSPLY Sirona Inc Azioni (XRAY) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
5.83%
953.00
1,012.00 947.00 1,028.00 978.00
Cost Of Revenue
8.78%
447.00
490.00 452.00 478.00 459.00
Gross Profit
3.07%
506.00
522.00 495.00 550.00 519.00
Operating Expenses
3.34%
464.00
449.00 731.00 470.00 521.00
Interest Income/Expense
21.74%
18.00
23.00 18.00 21.00 19.00
Benefits Costs and Expenses
3.46%
922.00
955.00 1,197.00 982.00 1,006.00
Costs And Expenses
3.46%
922.00
955.00 1,197.00 982.00 1,006.00
Operating Income/Loss
42.47%
42.00
73.00 -236.00 80.00 -2.00
Income/Loss From Continuing Operations Before Tax
45.61%
31.00
57.00 -250.00 46.00 -28.00
Income Tax Expense/Benefit, Deferred
60.87%
-9.00
-23.00 -24.00 -62.00 -21.00
Income Tax Expense/Benefit
193.33%
14.00
-15.00 16.00 -39.00 -5.00
Income/Loss From Continuing Operations After Tax
76.39%
17.00
72.00 -266.00 85.00 -23.00
Net Income/Loss
76.39%
17.00
72.00 -266.00 85.00 -23.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
120.00%
-1.00
5.00 - -1.00 -4.00
Basic Average Shares
29,729%
207.40
-0.70 211.80 211.90 214.50
Diluted Average Shares
29,886%
208.50
-0.70 211.80 213.10 214.50
Basic Earnings Per Share
71.88%
0.09
0.32 -1.25 0.41 -0.09
Diluted Earnings Per Share
71.88%
0.09
0.32 -1.25 0.40 -0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
medical_instruments_supplies ATR
$145.83
price up icon 0.00%
medical_instruments_supplies TFX
$209.30
price down icon 0.85%
$72.14
price down icon 0.47%
medical_instruments_supplies BAX
$33.74
price up icon 1.29%
medical_instruments_supplies COO
$94.20
price down icon 0.64%
medical_instruments_supplies WST
$336.29
price down icon 0.63%
Capitalizzazione:     |  Volume (24 ore):